Active Substance: Cholic acid.
Overview
Welcome to Dwaey, specifically on ORPHACOL 250 mg page.
This medicine contains an important and useful components, as it consists of
Cholic acidis available in the market in concentration
Dextrose / Sodium / Potassium
Electrolyte Imbalance: Monitor patients for signs of electrolyte disturbances, especially in those with renal impairment or on diuretics. Hyperglycemia: Use with caution in diabetic patients due to the dextrose component. Regular monitoring of blood glucose levels is advised. Fluid Overload: Patients with congestive heart failure or renal insufficiency should be monitored for signs of fluid overload. Allergic Reactions: Assess for any history of hypersensitivity to any of the components. Pediatric Use: Safety and efficacy in children under 2 years have not been established.
Respiratory Conditions: Relief of chest congestion associated with common cold, bronchitis, and other respiratory tract infections. Electrolyte Replenishment: Correction of mild to moderate dehydration and electrolyte imbalances. Energy Supply: Provision of calories in patients requiring nutritional supplementation
Hypersensitivity: Known allergy to dextrose, sodium, potassium, guaifenesin, or any excipients. Hyperkalemia: Elevated serum potassium levels. Hypernatremia: Elevated serum sodium levels. Anuria: Absence of urine production, indicating severe renal impairment. Uncontrolled Diabetes Mellitus: Due to the dextrose content
Common: Nausea Vomiting Diarrhea Headache Serious: Electrolyte disturbances (e.g., hyperkalemia, hypernatremia) Hyperglycemia Allergic reactions (e.g., rash, itching, swelling) Renal dysfunction
Information not available
Dextrose: Provides a source of calories and fluid for patients requiring nutritional support. Sodium and Potassium: Essential electrolytes that help maintain fluid balance, nerve function, and muscle function. Guaifenesin: Acts as an expectorant by thinning mucus in the airways, making it easier to cough up and clear from the respiratory tract.
Diuretics: May enhance the risk of electrolyte imbalances. ACE Inhibitors: Concomitant use may increase the risk of hyperkalemia. Insulin and Oral Hypoglycemics: Dextrose may affect blood glucose levels, necessitating dosage adjustments. Lithium: Sodium-containing solutions may affect lithium levels.
Pregnancy: Use only if clearly needed and if the potential benefit justifies the potential risk to the fetus. Lactation: Caution is advised when administering to breastfeeding mothers; consult healthcare provider.
Dosage: Administer as directed by a healthcare professional, based on the patient's clinical condition and laboratory results. Frequency: Typically administered every 6 to 8 hours, but may vary depending on the indication and patient response.
Dosage: Dosing in pediatric patients should be determined by a healthcare provider, considering age, weight, and clinical condition. Note: Safety and efficacy in children under 2 years have not been established
Adjustment: In patients with renal impairment, dosage adjustments may be necessary to prevent accumulation of electrolytes and fluid overload. Monitoring: Regular monitoring of renal function and electrolyte levels is recommended.
Route: Oral administration is common; ensure the patient is able to swallow and has no contraindications to oral intake. Instructions: Shake the bottle well before use to ensure uniform distribution of ingredients. Measure the dose accurately using a proper measuring device. Administer with or without food, as advised by the healthcare provider. Maintain adequate hydration unless contraindicated.